Stay updated on Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial
Sign up to get notified when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.

Latest updates to the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedLocations section expanded to list numerous US states and Canadian provinces, with revision tag v3.3.3. The update reorganizes location data for the study.SummaryDifference2%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing Revision: v3.3.1. No substantive study details or page functionality are affected.SummaryDifference0.0%

- Check36 days agoChange DetectedListed site updated from University of Florida Health Science Center - Gainesville to UF Health Cancer Institute - Gainesville. Added Informed Consent Form PDFs for Part A (Safety Phase) and Part B (Efficacy Phase) with Revision: v3.3.1, and included a Last Update Posted (Estimated) timestamp.SummaryDifference0.5%

- Check43 days agoChange DetectedRemoved the government funding status notice banner from the page, which previously warned that information may not be up to date due to appropriations and directed users to the opm.gov status page.SummaryDifference0.2%

- Check58 days agoChange DetectedThe two screenshots depict the same study page with minor UI/layout adjustments; core study content such as the title, objectives, eligibility, and outcomes remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check87 days agoChange DetectedCore page now includes a government funding/operating-status notice and a new version v3.2.0, replacing the older v3.0.2.SummaryDifference2%

Stay in the know with updates to Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.